Małgorzata Milewska

Overexpression of the microRNA miR‐433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells

Karolina Weiner‐Gorzel, Eugene Dempsey, Małgorzata Milewska et al. · Cancer Medicine · 2015 · 164 citations · Full text

Medicine, Cancer Biology, Oncology +17

Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies

Sinéad Toomey, Alex J. Eustace, Joanna Fay et al. · Breast Cancer Research · 2017 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of novel spartin‐interactors shows spartin is a multifunctional protein

Małgorzata Milewska, James McRedmond, P. Byrne · Journal of Neurochemistry · 2009 · 29 citations

Life Sciences, Molecular Biology, Neurology +17

Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH)

Damien Côté, Alex J. Eustace, Sinéad Toomey et al. · PLoS ONE · 2018 · 23 citations · Full text

Medicine, Molecular Genetics, Oncology +17

A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib

John J. O’Shea, Mattia Cremona, Clare Morgan et al. · Oncotarget · 2017 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17